Board of directors

Thomas Pollare

Thomas Pollare

Chairman of the board

Education: M.D., Ph.D

Elected to the board: 2013-09-24

Chairman from 2017-07-21



Past experience: Former CEO Global Medical Investments, former partner with venture capital firm 3i. VP roles at Pharmacia and Schering-Plough Research Institute. Board experience in major corporations as well as start-ups and venture investing.

Shares: 113 275 (via Oncolution AB) & warrants 15 000.

Yong Chul Shin

Yong Chul Shin

Board Director

Education: B.Sc., Ph.D

Elected to the board: 2017-06-07




Past experience: Current CEO and Chairman of Amicogen Inc. South Korea. Former professor of Gyungsang National University, former committee member of the Korean Food and Drug Administration. Previous journal editor of the Korea Society for Microbiology and Biotechnology.

Shares 1 912 000 (via Amicogen Inc.).

Patrick van de Velde

Patrick van de Velde

Board Director

Education: M.Sc. Industrial Engineering Biochemistry, MBA

Elected to the board: 2017-06-07




Past experience: Current General Manager and Board Member Promega Biotech AB, previous head of marketing Europe at GE Health and sales & business development manager at Sigma Aldrich Sweden.

Shares: 15 500, & warrants 15 000.

Lena Söderström

Lena Söderström

Board Director

Education: B.Sc. & Executive MBA in Medical Science from Uppsala University

Elected to the board: 2018-05-18




Past experience: CEO of Senzime. Thirty years experience in management positions in international pharmaceutical companies and the medical device industry. Broad range of experience includes positions e.g. people and project management, business development, international marketing and manufacturing. Board member of Uppsala universitet Holding AB (UUAB), SLU Holding AB, Genovis AB, Dicot AB and member of the Chamber Council at Stockholm Chamber of Commerce.

Shares: 10 000 & warrants 15 000.

Kirsti Gjellan

Kirsti Gjellan

Board Director

Education: M.Sc. (Pharm), Ph.D (Pharm Technology)

Elected to the board: 2018-05-18





Past experience: More than 30 years of experience from Pharmaceutical industry covering Discovery, Proof of Concept, Pharmaceutical Development, Quality Operations in Manufacturing, EHS, Right First Time/Lean/Six Sigma and site leader management as well as managing director.

All work experience has been generated in the dynamic between local and global organizations to create the most business value. Has worked as a Leader/manager and Change Agent since 1989.

Shares: 10 000 & warrants 15 000.